Trial Profile
A Phase 2, Randomized, Multicenter, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing HT-0712 With Placebo in Subjects With Age-Associated Memory Impairment (AAMI)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Apr 2015
Price :
$35
*
At a glance
- Drugs HT 0712 (Primary)
- Indications Memory disorders
- Focus Therapeutic Use
- Sponsors Dart NeuroScience
- 02 Apr 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 19 Dec 2013 New trial record